Download presentation
Presentation is loading. Please wait.
Published byHamdani Lie Modified over 6 years ago
1
Fig. 1 CSF1 is increased in blood of melanoma patients and correlates with disease progression.
CSF1 is increased in blood of melanoma patients and correlates with disease progression. (A) CSF1 concentration in the plasma of healthy donors (n = 12) and melanoma patients (n = 15), quantified by enzyme-linked immunosorbent assay (ELISA). Data are means ± SEM. (B) Correlation between LDH and CSF1 concentration in the serum of nine melanoma patients, of which the LDH concentration was available, using Spearman’s correlation coefficient. The dashed line indicates least-squares linear fit. (C) CSF1 concentration in the serum of melanoma patients (40 samples from 27 patients analyzed at different time points of disease progression). Patients were grouped by disease stage at the time of sample withdrawal. Data are means ± SEM. n, number of samples; rho, Spearman’s correlation coefficient; NS, not significant. Statistical analysis in (A) and (C) by Mann-Whitney U test. *P < 0.05; ****P < Natalie J. Neubert et al., Sci Transl Med 2018;10:eaan3311 Published by AAAS
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.